Search
for
Sort by
Research 61–90 of 142
- Gynecologic and andrologic dermatology and the metabolic syndrome
- 1406 DETECTION OF MEMBRANE ANDROGEN-BINDING SITE IN LIVING RAT PROSTATE AND EVALUATION OF ITS ROLE IN PROSTATE BLOOD FLOW REGULATION
- RP-HPLC-Based Stability-Indicating Analytical Method for Concurrent Determination of Finasteride and Tadalafil: Development and Validation
- Systematic review: interventions in sickle cell disease-related priapism in reducing overall morbidity, recurrence, and side effects
- 133 Female Post-Finasteride Syndrome: It’s Not Just A Man’s World
- The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism
- Adipose-Derived Stem/Stromal Cells
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Gender Differences in Cardiac Hypertrophy
- REPORTS: Summary of the Recommendations on Sexual Dysfunctions in Women
- Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5‐Alpha Reductase Inhibitor Therapy
- The Neurobiology of Sexual Function
- Common urologic diseases in older men and their treatment: how they impact fertility
- Non-surgical management of BPH: An updated review of current literature and state of the art on natural compounds and medical therapy
- Benign Prostatic Hyperplasia and Sexual Dysfunction: Review of the Impact of New Medical and Surgical Therapies on Sexual Health
- Entrepreneurship in Off-Label Drug Prescription: Just What the Doctor Ordered!
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- Trimodal mini-invasive therapy for stable-phase Peyronie's disease: a two-center real-life prospective pilot study
- Scientific augmentation of BPH and its treatment in Unani medicine the review
- Review Article: Practical Aspects of Testosterone Deficiency Syndrome in Clinical Urology
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- Medikamentöse Therapie des benignen Prostatasyndroms
- PD49-03 IS TADALAFIL ASSOCIATED WITH DECREASED RISK OF MAJOR ADVERSE CARDIAC EVENTS OR VENOUS THROMBOEMBOLISM IN MEN WITH LOWER URINARY TRACT SYMPTOMS?
- Sustainable UV approaches supported by greenness and whiteness assessments for estimating a recently FDA-approved combination for managing urologic disorders: Tukey's test
- Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants
- Highlights from the Literature
- Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014)
- Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia
- Cyclosporine-A-Induced Intracranial Thrombotic Complications: Systematic Review and Cases Report
- Effects of androgen on extracellular vesicles from endothelial cells in rat penile corpus cavernosum